
|Articles|March 11, 2020
Supplements and Featured Publications
- Evidence-Based Recommendations, Real-World Utilization, and Considerations in the Total Cost of Care in COPD Treatment Strategies
Evidence-Based Recommendations, Real-World Utilization, and Considerations in the Total Cost of Care in COPD Treatment Strategies
Advertisement
This AJMC® Clinical Brief explores the latest evidence-based guidelines on the management of chronic obstructive pulmonary disease (COPD), recent research with real-world utilization data, and the implications of prescription and utilization patterns on COPD healthcare resource utilization and total cost of care.
Newsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.
Advertisement
Advertisement
Advertisement
Trending on AJMC
1
TrumpRx Launch Brings Savings—and Uncertainty
2
How Do GLP-1 Agonists Fit Into Stroke Care?
3
Aligning Treatment Goals in IgA Nephropathy: Applying KDIGO’s Dual-Pathway Framework to Clinical Decision-Making
4
Addressing Disparities at Every Step of the Stroke Care Pathway: Luke Messac, MD, PhD
5










